老年人恶性胆道梗阻经皮介入治疗临床分析  

Clinical analysis of percutanneous intervention for elderly patients with malignant obstructive jaundice

作　　者：方晓[1] 徐艺桐[2] 

机构地区：[1]中国医科大学附属第一临床学院放射介入科,辽宁沈阳110000 [2]中国医科大学

出　　处：《中国当代医药》2011年第19期30-31,共2页China Modern Medicine

摘　　要：目的:观察和分析老年人恶性胆道梗阻经皮介入治疗的临床价值。方法:收集本院介入病房收治的大于70岁的患有恶性胆道梗阻的老年人患者98例,其中60例接受PTCD,38例接受经皮胆道内支架置入术包括15例分两步先行外引流术后择期行支架植入术。结果:27例发生并发症,死亡3例。除死亡患者外,患者黄疸均不同程度减轻,胆红素指标明显好转。结论:老年恶性胆道梗阻患者经皮介入治疗是姑息减黄比较安全的方法,围术期积极处理极为重要,可以明显减低并发症及死亡率。Objective：To study the clinical value of percutaneous intervention which include perutaneous transhepatic cholangial dranage and stenting for elderly patients with malignant obstructive jaudice.Methods：Data of 98 cases with malignant obstructive jaundice in elderly were collected.60 cases got PTCD and 38 got stenting including 15 cases got PTCD and stenting by two steps.All successed in the intervention.Results：All successed in the intervention.The levels of serum total bilirubin（TB） decrease significantly after the procedure.And complications occurred in 27 cases and 4 death.Except for the death,all cases got satisfying results.Conclusion：Percutaneous intervention is safe and effectives as a palliative treatment for elderly patients suffering from malignant obstructive jaundice with low incidence of critical complications and low fatality,and reasonable per-intervention treatment is very important for decreasing complications and fatality.

关 键 词：梗阻性黄疸 并发症 经皮介入治疗 恶性 

分 类 号：R57[医药卫生—消化系统]